BR112012005540A2 - composições e métodos para melhora da função cognitiva e funções relacionadas em animais - Google Patents
composições e métodos para melhora da função cognitiva e funções relacionadas em animaisInfo
- Publication number
- BR112012005540A2 BR112012005540A2 BR112012005540A BR112012005540A BR112012005540A2 BR 112012005540 A2 BR112012005540 A2 BR 112012005540A2 BR 112012005540 A BR112012005540 A BR 112012005540A BR 112012005540 A BR112012005540 A BR 112012005540A BR 112012005540 A2 BR112012005540 A2 BR 112012005540A2
- Authority
- BR
- Brazil
- Prior art keywords
- animals
- compositions
- methods
- cognitive function
- related functions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/132—Heterocyclic compounds containing only one nitrogen as hetero atom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/179—Colouring agents, e.g. pigmenting or dyeing agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q30/00—Commerce
- G06Q30/02—Marketing; Price estimation or determination; Fundraising
- G06Q30/0241—Advertisements
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Polymers & Plastics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Business, Economics & Management (AREA)
- Accounting & Taxation (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Strategic Management (AREA)
- Finance (AREA)
- Development Economics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Economics (AREA)
- Marketing (AREA)
- Physics & Mathematics (AREA)
- General Business, Economics & Management (AREA)
- General Physics & Mathematics (AREA)
- Theoretical Computer Science (AREA)
- Game Theory and Decision Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Entrepreneurship & Innovation (AREA)
- General Chemical & Material Sciences (AREA)
- Botany (AREA)
- Inorganic Chemistry (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27640209P | 2009-09-11 | 2009-09-11 | |
PCT/US2010/002440 WO2011031304A2 (en) | 2009-09-11 | 2010-09-02 | Compositions and methods for enhancing cognitive and related functions in animals |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112012005540A2 true BR112012005540A2 (pt) | 2016-04-26 |
Family
ID=43732999
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012005540A BR112012005540A2 (pt) | 2009-09-11 | 2010-09-02 | composições e métodos para melhora da função cognitiva e funções relacionadas em animais |
Country Status (12)
Country | Link |
---|---|
US (1) | US20120171303A1 (pt) |
EP (1) | EP2464350B1 (pt) |
JP (1) | JP5863656B2 (pt) |
CN (1) | CN103533933A (pt) |
AU (1) | AU2010293065B2 (pt) |
BR (1) | BR112012005540A2 (pt) |
CA (1) | CA2773523A1 (pt) |
ES (1) | ES2593880T3 (pt) |
MX (1) | MX2012002996A (pt) |
RU (1) | RU2569743C2 (pt) |
WO (1) | WO2011031304A2 (pt) |
ZA (1) | ZA201202561B (pt) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014505031A (ja) * | 2010-12-07 | 2014-02-27 | ネステク ソシエテ アノニム | 動物の睡眠促進に有用な方法及び組成物 |
US10286005B2 (en) | 2015-01-08 | 2019-05-14 | Ezaki Glico Co., Ltd. | Antioxidant agent, and antioxidant cosmetic and UV care cosmetic |
CN104886574B (zh) * | 2015-06-04 | 2017-06-13 | 南京贝杉国际贸易有限公司 | 一种改善睡眠保护视力的中老年保健食品及其制备方法 |
CA2912611C (en) * | 2015-11-18 | 2024-01-30 | Fb Health S.P.A. | Homotaurine compounds, compositions and formulations for animal care |
US11478011B2 (en) | 2015-12-14 | 2022-10-25 | Societe Des Produits Nestle S.A. | Nutritional compositions and infant formula for promoting de novo myealination |
CN108463122A (zh) * | 2015-12-14 | 2018-08-28 | 雀巢产品技术援助有限公司 | 用于促进脑的髓鞘形成的营养组合物和婴儿配方食品 |
JP2017218424A (ja) | 2016-06-08 | 2017-12-14 | アスタリール株式会社 | 認知機能向上のための運動療法において使用するための、カロテノイドを含む認知機能向上組成物 |
SG10201900604TA (en) * | 2019-01-23 | 2020-08-28 | Agency For Science Technology And Research Astarstar | Pre-natal beta-cryptoxanthin benefits children |
CN109892247B (zh) * | 2019-04-19 | 2023-08-18 | 桂林医学院 | 一种猫参与的检测大鼠认知功能的实验装置 |
JP6861264B1 (ja) * | 2019-11-19 | 2021-04-21 | 慶昌 木島 | 組成物 |
CN111838321A (zh) * | 2020-08-18 | 2020-10-30 | 青岛大学 | 一种含叶黄素和益生元的老年营养包及其制备方法 |
KR102517992B1 (ko) * | 2022-05-26 | 2023-04-05 | 주식회사 에이엘 네트웍스 | 인지장애 및 뇌기능 개선을 위한 펫푸드 조성물 및 이의 제조 방법 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6048846A (en) * | 1998-02-26 | 2000-04-11 | Cochran; Timothy M. | Compositions used in human treatment |
PT1283038E (pt) * | 2000-05-16 | 2008-10-23 | Suntory Ltd | Composições normalizadoras do ritmo circadiano |
US20020120001A1 (en) * | 2000-10-13 | 2002-08-29 | Ashni Naturaceuticals, Inc. | Compositions containing tryptamines, cartenoids and tocotrienols and having synergistic antioxidant effect |
US6821997B1 (en) * | 2000-10-16 | 2004-11-23 | Victorio C. Rodriguez | Therapeutic and prophylactic treatment of aging and disorders of aging in humans |
US20040001817A1 (en) * | 2002-05-14 | 2004-01-01 | Giampapa Vincent C. | Anti-aging nutritional supplement |
CN1708480B (zh) * | 2002-07-29 | 2010-12-15 | 卡达克斯药物公司 | 用于抑制和改善疾病的类胡萝卜素结构类似物 |
US20070111933A1 (en) * | 2003-06-02 | 2007-05-17 | Kopchick John J | Diagnosis and treatment methods related to aging, especially of liver |
IL158139A0 (en) * | 2003-09-25 | 2004-09-27 | Enzymotec Ltd | Stabilized formulations of phosphatidyl serine |
WO2005037215A2 (en) * | 2003-10-14 | 2005-04-28 | Massachusetts Institute Of Technology | Compositions and methods for enhancing cognitive function and synaptic plasticity |
US20060039954A1 (en) * | 2003-12-23 | 2006-02-23 | Gierhart Dennis L | Ocular formulations with neuroprotectants to reduce Alzheimer and neurotoxic risks created by large zinc dosages |
US7262318B2 (en) * | 2004-03-10 | 2007-08-28 | Pfizer, Inc. | Substituted heteroaryl- and phenylsulfamoyl compounds |
IL162288A0 (en) * | 2004-06-01 | 2005-11-20 | Future Products Man S A | Compositions and methods for treating neurodegenerative disorders |
WO2007041418A2 (en) | 2005-09-30 | 2007-04-12 | Nestec S.A. | Methods and compositions for improving cognitive function |
JP2007126455A (ja) * | 2005-10-07 | 2007-05-24 | Fuji Chem Ind Co Ltd | 脳機能障害の改善剤 |
JP4993900B2 (ja) * | 2005-11-28 | 2012-08-08 | 国立大学法人 東京医科歯科大学 | 記憶障害抑制剤 |
HUE037129T2 (hu) | 2005-12-15 | 2018-08-28 | Nestec Sa | Kompozíciók és eljárások agyi funkció megõrzésére |
AU2007205996A1 (en) * | 2006-01-10 | 2007-07-26 | Pipex, Inc. | Pharmaceutical compositions and methods to achieve and maintain a targeted and stable copper status and prevent and treat copper-related central nervous system diseases |
CA2637329A1 (en) * | 2006-02-01 | 2007-08-09 | Nestec S.A. | Nutritional system and methods for increasing longevity |
US20090246186A1 (en) * | 2006-03-29 | 2009-10-01 | Kaneka Corporation | Agent for improving nervous system cell functions |
US7897637B2 (en) * | 2006-07-19 | 2011-03-01 | The Salk Institute For Biological Studies | Methods of using flavonoids to enhance memory |
WO2008083204A2 (en) * | 2006-12-28 | 2008-07-10 | Braincells, Inc. | Modulation of neurogenesis by melatoninergic ligands |
US20100076091A1 (en) * | 2007-02-14 | 2010-03-25 | Tohoku University | Composition and method for suppressing lipooxidation of erythrocyte |
PL2194781T5 (pl) | 2007-10-04 | 2021-11-15 | Société des Produits Nestlé S.A. | Kompozycje i sposoby wzmacniania funkcji poznawczych |
JP5979816B2 (ja) * | 2008-01-04 | 2016-08-31 | ネステク ソシエテ アノニム | 不飽和脂肪酸及び酸化窒素放出化合物を含む組成物、並びに認知機能及び関連の機能を高めるためのそれらの使用 |
RU2011107221A (ru) | 2008-07-30 | 2012-09-10 | Нестек С.А. (Ch) | Способы и композиции для профилактики, ослабления проявлений или терапии поражений, вызываемых ишемией и ишемиеподобными состояниями |
-
2010
- 2010-09-02 US US13/395,033 patent/US20120171303A1/en not_active Abandoned
- 2010-09-02 WO PCT/US2010/002440 patent/WO2011031304A2/en active Application Filing
- 2010-09-02 JP JP2012528790A patent/JP5863656B2/ja not_active Expired - Fee Related
- 2010-09-02 MX MX2012002996A patent/MX2012002996A/es active IP Right Grant
- 2010-09-02 CA CA2773523A patent/CA2773523A1/en not_active Abandoned
- 2010-09-02 RU RU2012114057/15A patent/RU2569743C2/ru not_active IP Right Cessation
- 2010-09-02 AU AU2010293065A patent/AU2010293065B2/en not_active Ceased
- 2010-09-02 EP EP10815735.5A patent/EP2464350B1/en not_active Not-in-force
- 2010-09-02 ES ES10815735.5T patent/ES2593880T3/es active Active
- 2010-09-02 CN CN201080050618.9A patent/CN103533933A/zh active Pending
- 2010-09-02 BR BR112012005540A patent/BR112012005540A2/pt not_active IP Right Cessation
-
2012
- 2012-04-10 ZA ZA2012/02561A patent/ZA201202561B/en unknown
Also Published As
Publication number | Publication date |
---|---|
RU2012114057A (ru) | 2013-10-20 |
EP2464350A2 (en) | 2012-06-20 |
ES2593880T3 (es) | 2016-12-13 |
EP2464350A4 (en) | 2014-06-18 |
ZA201202561B (en) | 2014-04-30 |
MX2012002996A (es) | 2012-04-11 |
JP2013510076A (ja) | 2013-03-21 |
JP5863656B2 (ja) | 2016-02-16 |
AU2010293065A1 (en) | 2012-04-05 |
WO2011031304A3 (en) | 2014-03-13 |
CN103533933A (zh) | 2014-01-22 |
CA2773523A1 (en) | 2011-03-17 |
RU2569743C2 (ru) | 2015-11-27 |
EP2464350B1 (en) | 2016-08-24 |
AU2010293065B2 (en) | 2016-05-05 |
US20120171303A1 (en) | 2012-07-05 |
WO2011031304A2 (en) | 2011-03-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012005540A2 (pt) | composições e métodos para melhora da função cognitiva e funções relacionadas em animais | |
BRPI0916670A2 (pt) | estações ponderadas de isca para roedor e métodos relacionados | |
BRPI1007667A2 (pt) | condicionador capilar e composição | |
BR112012031446A2 (pt) | componentes e métodos para implantes | |
BRPI0910874A2 (pt) | composições e métodos para cuidado da pele | |
BR112012004979A2 (pt) | composições para o tratamento de semente e métodos | |
BRPI0921959A2 (pt) | métodos e composições para remoção de tatuagem | |
BRPI1008566A8 (pt) | métodos e composições para o diagnóstico e tratamento de câncer | |
BRPI1007972A2 (pt) | composições de combinação e métodos para o tratamento de câncer | |
BRPI1012525A2 (pt) | composições de nanopatículas isentas de príons e métodos para sua fabricação | |
BRPI1013302A2 (pt) | novas composições para tratamento de cmt e enfermidades relacionadas | |
BRPI0919238A2 (pt) | métodos e composições para o tratamento de câncer | |
BRPI1007600A2 (pt) | composições e métodos para tratamento de doenças cardiovasculares | |
BRPI1008564A2 (pt) | métodos e composições para o dignóstico e tratamento de câncer | |
BRPI1008326A2 (pt) | Composições e métodos para controlar nanatódeos | |
BRPI1011325A2 (pt) | composições e métodos para o tratamento de inflamação | |
BRPI1015079A2 (pt) | Hidroxitienoquinolonas e compostos relacionados como agentes anti-infecciosos | |
BRPI1013927A2 (pt) | métodos e composições para o tratamento de lúpus | |
BR112013015781A2 (pt) | compostos e métodos para reparação da pele | |
BRPI1006369A2 (pt) | cortina para abrigo de animais e abrigo de animais | |
BR112012004699A2 (pt) | Métodos e composições para lise química direta | |
BRPI1012359A2 (pt) | obras de arte de técnica mista e métodos de criação | |
BR112013016220A2 (pt) | composições alimentares para animais domésticos e métodos para tratar artrite e inflamação associada com artrite | |
BR112012004701A2 (pt) | compostos e composições para tratamento do câncer | |
BR112012005689A2 (pt) | composição de higiene pessoal e método para substituir silicone em composição de higiene pessoal |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2477 DE 26-06-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |